“Partnering with TransMed and Willowglade will bring strategic technology to IOBS and will aid in accelerating the expansion of our Triage System and Triage Pathways to leading community oncology practices in support of their value-based care success,” said Barbara McAneny, MD, CEO and CMO of IOBS.
CUPERTINO and MISSION VIEJO, Calif. (PRWEB) January 08, 2018
TransMed Systems (http://www.xbtransmed.com), an oncology focused healthcare technology, informatics and clinical trial company, and Willowglade Technologies Corporation (http://www.willowgladetechnologies.com), a provider of the Patient Involvement Platform and surrounding solutions for clinical care and patient education, are announcing a partnership to replace the Allscripts-acquired technology currently supporting the Innovative Oncology Business Solutions (IOBS) Triage System (http://www.innovativeobs.com/triage-system). TransMed Systems and Willowglade Technologies will support the full breadth of the IOBS Triage System, including the comprehensive set of triage protocols focusing on patient symptoms, along with the IOBS Triage Pathways for step-by-step clinical decision-making. The infrastructure and solution will support the National Cancer Care Alliance’s (NCCA) Diagnostic and Therapeutic Pathways.
“Partnering with TransMed and Willowglade, both leading technology providers to community oncology practices, will bring strategic technology to IOBS and will aid in accelerating the expansion of our Triage System and Triage Pathways to leading community oncology practices nationwide in support of their value-based care success,” said Barbara L McAneny, MD, CEO and Chief Medical Officer of IOBS. “By improving the timeliness and coordination of care, while also reducing cost through avoidance of unnecessary emergency department (ED) and inpatient hospital visits, IOBS will be better able to enhance patient outcomes. That mission is becoming increasingly important as oncology practices participating in the OCM or future APMs need interventions such as our triage pathways to directly reduce costs for which they are held accountable.”
Oncology practices utilizing IOBS Triage Pathways enable Nurse Navigators to quickly assess calls from patients needing care. The Triage Pathways System provides evidence-based decision support to allow nurses to effectively address patient concerns and navigate the patient to the optimal site of care. As John Papandrea, CEO of Willowglade Technologies Corporation adds, “The Patient Involvement Platform can be configured to support Triage Pathways for IOBS or other specific use cases for practices, including custom content, custom pathways and custom follow-up education for patients. This allows practices to implement custom triage or other care pathways based on their required organizational standards.”
According to Carla Balch, President and COO of TransMed Systems, Inc., “The best clinical and operational care for patients is driven by a modern and intuitive technology infrastructure. The care team’s use of the clinical decision support capabilities systematically provides every cancer patient with a full assessment to ensure top level care and outcomes. TransMed, combined with Willowglade’s new Patient Involvement Platform, will bring an expanded set of capabilities to the IOBS Triage System, oncology treatment centers and patients. We develop our technology to enrich the lives of oncologists and patients fighting cancer.”
The new TransMed Systems infrastructure with Willowglade Technologies is available for deployment in Q1 2018.
About TransMed Systems, Inc. (http://www.xbtransmed.com)
TransMed Systems provides software solutions and services that facilitate the exploration, reporting and analysis of clinical, molecular and healthcare operational data. TransMed’s Clinical Trials Suite provides an integrated Precision Medicine platform enabling clinical and research organizations to aggregate data from multiple resources, easily explore data and perform research and/or practice specific analysis. TransMed’s unlocks the potential of the healthcare repository by tightly integrating analytics with aggregated data providing sophisticated matching of potential clinical trial patients to complex clinical trials. Our solutions are used by clinical research teams in Life Science companies, CROs, oncology service lines in community, health system and academic settings.
About Willowglade Technologies Corporation (http://www.willowgladetechnologies.com)
Willowglade Technologies is a provider of technology solutions to the healthcare community, with a focus on enabling involvement of the patient in their care from “Clinical Trial to Clinical Care” using the innovative Patient Involvement Platform. This platform enhances patient education, communication, collaboration and all facets of care plan and program adherence.
About Innovative Oncology Business Solutions, Inc. (http://www.innovativeobs.com)
Innovative Oncology Business Solutions, Inc, was created in 2012 to administer the $19.8 Million COME HOME grant. Currently, IOBS provides administrative support to the National Cancer Care Alliance and provides consulting services to practices to crate improved affordable practice transformations to meet Medical Home Accreditation while positioning them for value-based contracting success. Learn more at http://www.innovativeobs.com.